Related Experiment Videos
Additive effects of inducers and fasting on acetaminophen hepatotoxicity
Biochemical Pharmacology
|August 15, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma.
Cancer investigation·2007
Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection.
Journal of viral hepatitis·2005
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.
Journal of viral hepatitis·2005
TEAD upregulation promotes osimertinib resistance in NSCLC by recruiting YAP into the nucleus.
Biochemical pharmacology·2026
Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism.
Biochemical pharmacology·2026
Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.
Biochemical pharmacology·2026
Allosteric kinase inhibition in hematological malignancies: from asciminib to emerging regulatory sites.
Biochemical pharmacology·2026
Connexin-43 remodeling drives atrial arrhythmias in hypothyroidism: ranolazine as a potential therapeutic strategy.
Biochemical pharmacology·2026
MANF attenuates cholestatic liver injury by enhancing GRP78-PERK interaction.
Biochemical pharmacology·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026